世界の胆管腫瘍市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Biliary Tumor Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5618
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、100ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、胆管腫瘍の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、手術、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・胆管腫瘍の市場動向
・企業の競争状況、市場シェア
・胆管腫瘍の種類別市場規模と予測2016-2027（医薬品、手術、その他）
・胆管腫瘍の用途別市場規模と予測2016-2027（病院、診療所、その他）
・胆管腫瘍の北米市場規模2016-2027（アメリカ、カナダ）
・胆管腫瘍の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・胆管腫瘍のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・胆管腫瘍の中南米市場規模2016-2027（メキシコ、ブラジル）
・胆管腫瘍の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（NuCana、NeoGenomics、Novartis、GlaxoSmithKline、Southwest Oncology Group）
・結論

Biliary Tumor is a form of cancer that develops in the bile duct system, which connects the liver, gallbladder, and small intestine, moving bile – a fluid that helps digest fats – to the small intestine.

Market Analysis and Insights: Global Biliary Tumor Market
The global Biliary Tumor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biliary Tumor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biliary Tumor market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biliary Tumor market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biliary Tumor market.

Global Biliary Tumor Scope and Market Size
Biliary Tumor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biliary Tumor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Mecine
Surgery
Other

Segment by Application
Hospitals
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
NuCana
NeoGenomics
Novartis
GlaxoSmithKline
Southwest Oncology Group

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biliary Tumor Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mecine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Biliary Tumor Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Biliary Tumor Market Perspective (2016-2027)
2.2 Biliary Tumor Growth Trends by Regions
2.2.1 Biliary Tumor Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biliary Tumor Historic Market Share by Regions (2016-2021)
2.2.3 Biliary Tumor Forecasted Market Size by Regions (2022-2027)
2.3 Biliary Tumor Industry Dynamic
2.3.1 Biliary Tumor Market Trends
2.3.2 Biliary Tumor Market Drivers
2.3.3 Biliary Tumor Market Challenges
2.3.4 Biliary Tumor Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Biliary Tumor Players by Revenue
3.1.1 Global Top Biliary Tumor Players by Revenue (2016-2021)
3.1.2 Global Biliary Tumor Revenue Market Share by Players (2016-2021)
3.2 Global Biliary Tumor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biliary Tumor Revenue
3.4 Global Biliary Tumor Market Concentration Ratio
3.4.1 Global Biliary Tumor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biliary Tumor Revenue in 2020
3.5 Biliary Tumor Key Players Head office and Area Served
3.6 Key Players Biliary Tumor Product Solution and Service
3.7 Date of Enter into Biliary Tumor Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Biliary Tumor Breakdown Data by Type
4.1 Global Biliary Tumor Historic Market Size by Type (2016-2021)
4.2 Global Biliary Tumor Forecasted Market Size by Type (2022-2027)

5 Biliary Tumor Breakdown Data by Application
5.1 Global Biliary Tumor Historic Market Size by Application (2016-2021)
5.2 Global Biliary Tumor Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Biliary Tumor Market Size (2016-2027)
6.2 North America Biliary Tumor Market Size by Type
6.2.1 North America Biliary Tumor Market Size by Type (2016-2021)
6.2.2 North America Biliary Tumor Market Size by Type (2022-2027)
6.2.3 North America Biliary Tumor Market Size by Type (2016-2027)
6.3 North America Biliary Tumor Market Size by Application
6.3.1 North America Biliary Tumor Market Size by Application (2016-2021)
6.3.2 North America Biliary Tumor Market Size by Application (2022-2027)
6.3.3 North America Biliary Tumor Market Size by Application (2016-2027)
6.4 North America Biliary Tumor Market Size by Country
6.4.1 North America Biliary Tumor Market Size by Country (2016-2021)
6.4.2 North America Biliary Tumor Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Biliary Tumor Market Size (2016-2027)
7.2 Europe Biliary Tumor Market Size by Type
7.2.1 Europe Biliary Tumor Market Size by Type (2016-2021)
7.2.2 Europe Biliary Tumor Market Size by Type (2022-2027)
7.2.3 Europe Biliary Tumor Market Size by Type (2016-2027)
7.3 Europe Biliary Tumor Market Size by Application
7.3.1 Europe Biliary Tumor Market Size by Application (2016-2021)
7.3.2 Europe Biliary Tumor Market Size by Application (2022-2027)
7.3.3 Europe Biliary Tumor Market Size by Application (2016-2027)
7.4 Europe Biliary Tumor Market Size by Country
7.4.1 Europe Biliary Tumor Market Size by Country (2016-2021)
7.4.2 Europe Biliary Tumor Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Biliary Tumor Market Size (2016-2027)
8.2 Asia-Pacific Biliary Tumor Market Size by Type
8.2.1 Asia-Pacific Biliary Tumor Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biliary Tumor Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biliary Tumor Market Size by Type (2016-2027)
8.3 Asia-Pacific Biliary Tumor Market Size by Application
8.3.1 Asia-Pacific Biliary Tumor Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biliary Tumor Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biliary Tumor Market Size by Application (2016-2027)
8.4 Asia-Pacific Biliary Tumor Market Size by Region
8.4.1 Asia-Pacific Biliary Tumor Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biliary Tumor Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Biliary Tumor Market Size (2016-2027)
9.2 Latin America Biliary Tumor Market Size by Type
9.2.1 Latin America Biliary Tumor Market Size by Type (2016-2021)
9.2.2 Latin America Biliary Tumor Market Size by Type (2022-2027)
9.2.3 Latin America Biliary Tumor Market Size by Type (2016-2027)
9.3 Latin America Biliary Tumor Market Size by Application
9.3.1 Latin America Biliary Tumor Market Size by Application (2016-2021)
9.3.2 Latin America Biliary Tumor Market Size by Application (2022-2027)
9.3.3 Latin America Biliary Tumor Market Size by Application (2016-2027)
9.4 Latin America Biliary Tumor Market Size by Country
9.4.1 Latin America Biliary Tumor Market Size by Country (2016-2021)
9.4.2 Latin America Biliary Tumor Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Biliary Tumor Market Size (2016-2027)
10.2 Middle East & Africa Biliary Tumor Market Size by Type
10.2.1 Middle East & Africa Biliary Tumor Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biliary Tumor Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biliary Tumor Market Size by Type (2016-2027)
10.3 Middle East & Africa Biliary Tumor Market Size by Application
10.3.1 Middle East & Africa Biliary Tumor Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biliary Tumor Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biliary Tumor Market Size by Application (2016-2027)
10.4 Middle East & Africa Biliary Tumor Market Size by Country
10.4.1 Middle East & Africa Biliary Tumor Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biliary Tumor Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 NuCana
11.1.1 NuCana Company Details
11.1.2 NuCana Business Overview
11.1.3 NuCana Biliary Tumor Introduction
11.1.4 NuCana Revenue in Biliary Tumor Business (2016-2021)
11.1.5 NuCana Recent Development
11.2 NeoGenomics
11.2.1 NeoGenomics Company Details
11.2.2 NeoGenomics Business Overview
11.2.3 NeoGenomics Biliary Tumor Introduction
11.2.4 NeoGenomics Revenue in Biliary Tumor Business (2016-2021)
11.2.5 NeoGenomics Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Biliary Tumor Introduction
11.3.4 Novartis Revenue in Biliary Tumor Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Biliary Tumor Introduction
11.4.4 GlaxoSmithKline Revenue in Biliary Tumor Business (2016-2021)
11.4.5 GlaxoSmithKline Recent Development
11.5 Southwest Oncology Group
11.5.1 Southwest Oncology Group Company Details
11.5.2 Southwest Oncology Group Business Overview
11.5.3 Southwest Oncology Group Biliary Tumor Introduction
11.5.4 Southwest Oncology Group Revenue in Biliary Tumor Business (2016-2021)
11.5.5 Southwest Oncology Group Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Biliary Tumor Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mecine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Biliary Tumor Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biliary Tumor Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Biliary Tumor Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Biliary Tumor Market Share by Regions (2016-2021)
Table 9. Global Biliary Tumor Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Biliary Tumor Market Share by Regions (2022-2027)
Table 11. Biliary Tumor Market Trends
Table 12. Biliary Tumor Market Drivers
Table 13. Biliary Tumor Market Challenges
Table 14. Biliary Tumor Market Restraints
Table 15. Global Biliary Tumor Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Biliary Tumor Market Share by Players (2016-2021)
Table 17. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Tumor as of 2020)
Table 18. Ranking of Global Top Biliary Tumor Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Biliary Tumor Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biliary Tumor Product Solution and Service
Table 22. Date of Enter into Biliary Tumor Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biliary Tumor Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Biliary Tumor Revenue Market Share by Type (2016-2021)
Table 26. Global Biliary Tumor Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Biliary Tumor Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Biliary Tumor Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Biliary Tumor Revenue Market Share by Application (2016-2021)
Table 30. Global Biliary Tumor Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Biliary Tumor Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Biliary Tumor Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Biliary Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Biliary Tumor Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Biliary Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Biliary Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Biliary Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Biliary Tumor Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Biliary Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Biliary Tumor Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Biliary Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Biliary Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Biliary Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Biliary Tumor Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Biliary Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Biliary Tumor Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Biliary Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Biliary Tumor Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Biliary Tumor Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Biliary Tumor Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Biliary Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Biliary Tumor Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Biliary Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Biliary Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Biliary Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Biliary Tumor Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Biliary Tumor Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Biliary Tumor Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Biliary Tumor Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Biliary Tumor Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Biliary Tumor Market Size by Country (2022-2027) & (US$ Million)
Table 62. NuCana Company Details
Table 63. NuCana Business Overview
Table 64. NuCana Biliary Tumor Product
Table 65. NuCana Revenue in Biliary Tumor Business (2016-2021) & (US$ Million)
Table 66. NuCana Recent Development
Table 67. NeoGenomics Company Details
Table 68. NeoGenomics Business Overview
Table 69. NeoGenomics Biliary Tumor Product
Table 70. NeoGenomics Revenue in Biliary Tumor Business (2016-2021) & (US$ Million)
Table 71. NeoGenomics Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Biliary Tumor Product
Table 75. Novartis Revenue in Biliary Tumor Business (2016-2021) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. GlaxoSmithKline Company Details
Table 78. GlaxoSmithKline Business Overview
Table 79. GlaxoSmithKline Biliary Tumor Product
Table 80. GlaxoSmithKline Revenue in Biliary Tumor Business (2016-2021) & (US$ Million)
Table 81. GlaxoSmithKline Recent Development
Table 82. Southwest Oncology Group Company Details
Table 83. Southwest Oncology Group Business Overview
Table 84. Southwest Oncology Group Biliary Tumor Product
Table 85. Southwest Oncology Group Revenue in Biliary Tumor Business (2016-2021) & (US$ Million)
Table 86. Southwest Oncology Group Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biliary Tumor Market Share by Type: 2020 VS 2027
Figure 2. Mecine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Biliary Tumor Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Other Case Studies
Figure 9. Biliary Tumor Report Years Considered
Figure 10. Global Biliary Tumor Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Biliary Tumor Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Biliary Tumor Market Share by Regions: 2020 VS 2027
Figure 13. Global Biliary Tumor Market Share by Regions (2022-2027)
Figure 14. Global Biliary Tumor Market Share by Players in 2020
Figure 15. Global Top Biliary Tumor Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Tumor as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Biliary Tumor Revenue in 2020
Figure 17. Global Biliary Tumor Revenue Market Share by Type (2016-2021)
Figure 18. Global Biliary Tumor Revenue Market Share by Type (2022-2027)
Figure 19. North America Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Biliary Tumor Market Share by Type (2016-2027)
Figure 21. North America Biliary Tumor Market Share by Application (2016-2027)
Figure 22. North America Biliary Tumor Market Share by Country (2016-2027)
Figure 23. United States Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Biliary Tumor Market Share by Type (2016-2027)
Figure 27. Europe Biliary Tumor Market Share by Application (2016-2027)
Figure 28. Europe Biliary Tumor Market Share by Country (2016-2027)
Figure 29. Germany Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Biliary Tumor Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Biliary Tumor Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Biliary Tumor Market Share by Region (2016-2027)
Figure 39. China Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Biliary Tumor Market Share by Type (2016-2027)
Figure 47. Latin America Biliary Tumor Market Share by Application (2016-2027)
Figure 48. Latin America Biliary Tumor Market Share by Country (2016-2027)
Figure 49. Mexico Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Biliary Tumor Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Biliary Tumor Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Biliary Tumor Market Share by Country (2016-2027)
Figure 55. Turkey Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Biliary Tumor Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. NuCana Revenue Growth Rate in Biliary Tumor Business (2016-2021)
Figure 59. NeoGenomics Revenue Growth Rate in Biliary Tumor Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Biliary Tumor Business (2016-2021)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Biliary Tumor Business (2016-2021)
Figure 62. Southwest Oncology Group Revenue Growth Rate in Biliary Tumor Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

以下、関連資料のご紹介

世界の胆道閉鎖症治療市場規模・現状・予測（2021年-2027年）

Global Biliary Atresia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3899 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、胆道閉鎖症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、手術治療）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界の原発性胆汁性胆管炎治療薬市場規模・現状・予測（2021年-2027年）

Global Primary Biliary Cholangitis Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4763 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、原発性胆汁性胆管炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オカリバ、ウルソジオール、その他）、用途別市場規模（病院、私立クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の胆道障害治療市場規模・現状・予測（2021年-2027年）

Global Biliary Tract Disorder Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5617 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、胆道障害治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、手術、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、...

世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Wilms' Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-6071 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ウィルムス腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カボザンチニブ、SEL-12034、ラコツモマブ、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメ...

世界の腫瘍塞栓市場規模・現状・予測（2021年-2027年）

Global Tumor Embolization Market Size, Status and Forecast 2021-2027
QFJ1-4989 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、腫瘍塞栓の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肝動脈塞栓術（TAE）、薬剤溶出性ビーズ化学塞栓術（DEB-TACE）、放射線塞栓術（RE）、その他）、用途別市場規模（病院、外科医院、専門クリ...

世界の消化管間質腫瘍分子診断市場規模・現状・予測（2021年-2027年）

Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4242 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、消化管間質腫瘍分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究所）、主要地域別市場規模...

世界の外科的腫瘍切除市場規模・現状・予測（2021年-2027年）

Global Surgical Tumor Ablation Market Size, Status and Forecast 2021-2027
QFJ1-5354 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、外科的腫瘍切除の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ラジオ波焼灼療法、マイクロ波焼灼療法、冷凍アブレーション、その他）、用途別市場規模（肝臓がん、乳がん、肺がん、前立腺がん、その他）、主要地...

世界の線維形成性小円形細胞腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Desmoplastic Small Round Cell Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4116 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、線維形成性小円形細胞腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（免疫療法、外科手術、化学療法、放射線療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の神経内分泌腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Neuroendocrine Tumor Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4567 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、神経内分泌腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エベロリムス、スニチニブ、ドタオクトレオテート、ランレオチド、オクトレオチド）、用途別市場規模（病院、クリニック、その他）、主要地域別...

世界の肥満細胞腫治療薬市場規模・現状・予測（2021年-2027年）

Global Mast Cell Tumor Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4463 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、肥満細胞腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外用薬、経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の胆道閉鎖症治療市場規模・現状・予測（2021年-2027年） Biliary atresia or extra hepatic ductopenia is an acquired disease of the liver. This disease is characterized by the obliteration of the extra hepatic biliary system which results in obstruction of the bile flow from the liver to gall bladder. Market Analysis and Insights: Global Biliary Atresia Tr…
世界の原発性胆汁性胆管炎治療薬市場規模・現状・予測（2021年-2027年） Primary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is an autoimmune disease of the liver. There is a dire need for curative therapy for primary biliary cholangitis across the world. This is because of the recurring nature of the disease. Currently, the only cure for th…
世界の胆道障害治療市場規模・現状・予測（2021年-2027年） Biliary Tract Disorder Treatment is treatments that used to treat biliary diseases. Biliary disease refers to diseases affecting the bile ducts, gallbladder and other structures involved in the production and transportation of bile. Market Analysis and Insights: Global Biliary Tract Disorder Treatme…
金属製胆管ステントのグローバル市場2021 The most common indication for biliary stenting is for treatment of obstructive jaundice from either benign or malignant causes. On occasion, stents are placed for management of bile leaks. Stents are made of either plastic or metal, and they are placed to provide internal drainage, eliminating the …
世界のウィルムス腫瘍治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Wilms' Tumor Treatment Market The global Wilms' Tumor Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…